Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Vaccine from Vietnam found effective in a trial in Kolkata A new reformulated oral cholera vaccine (ocv), earlier tested and found effective in Vietnam, was found to be safe in a cholera endemic region in Kolkata.
Fifteen years ago, at the height of Italy's 'Clean Hands' anticorruption campaign, police broke into the house of Duilio Poggiolini, head of the national committee for drug registration, and discovered gold bullion under his floorboards. For many Italians, the image of that gleaming bullion still resonates
the Drugs Controller General of India (dcgi) is preparing guidelines for linking the drug regulatory authority and the Indian patent office. The system called
Anil Urs / Bangalore July 30, 2008, 0:12 IST Indian biotechnology firms are steadily moving up the value chain by offering research and development (R&D;) services for global pharma companies to aid drug discovery and manufacture. Companies are offering services in drug discovery and validation based on pathway analysis (that …
P B Jayakumar / Mumbai July 29, 2008, 5:18 IST Dr Reddy's Laboratories, the country's third-biggest drugmaker, will form a joint venture with one of the world's biggest biotech companies to make biosimilars or generic versions of patented biotech drugs to take on Ranbaxy Laboratories, Reliance Life Sciences, among other …
Joe C Mathew / New Delhi July 24, 2008, 0:03 IST Two United States senators have asked the US Food and Drug Administration (USFDA) to provide details of market approvals given to all medicines sold by India's largest drug-maker Ranbaxy in that country. The senators, John Dingell and Bart Stupak, …
Ranbaxy said on Tuesday that UK's English Crown court has quashed the country's Serious Fraud Office (SFO) prosecution of the firm's subsidiary. This has come as a welcome breather for the company, which is facing investigations in US for selling sub-standard drugs. Ranbaxy said that the court also declined an …
P B Jayakumar / Mumbai July 23, 2008, 0:20 IST Pharmaceutical companies in the country offering any financial incentive to doctors to prescribe particular drugs may become a thing of the past if the drug manufacturers decide to follow the strict code of conduct being implemented by a US industry …
BS Reporter / New Delhi July 23, 2008, 0:52 IST Ranbaxy Laboratories today said it has won a two-year-old case against UK Serious Fraud Office (SFO) in the English Crown Court, a morale boosting relief to the domestic drug major. SFO had taken Ranbaxy's UK subsidiary, Ranbaxy (UK), to court …
Joe C Mathew / New Delhi July 23, 2008, 0:19 IST Boehringer Ingelheim, the $17-billion German pharma major that set up a subsidiary in India three years back, has decided to adopt a partnership model to tap the domestic market. The company is exploring collaborative research options. It will launch …
Former US president Bill Clinton has roped in four Indian and two Chinese pharmaceutical firms to cut the price of anti-malarial drugs by a whopping 30 per cent, which is likely to benefit 500 million people worldwide. The firms have also agreed to lower the price volatility of artemisinin, the …
Two US Congress members have expressed doubts over the quality of inspections conducted by the US Food and Drugs Administration (FDA) on Indian drug manufacturing facilities. Congressmen John Dingell and Bart Stupak have said the ongoing FDA-Ranbaxy row over alleged supply of "fraudulently approved and manufactured" medicines by Ranbaxy in …
P B Jayakumar / Mumbai July 19, 2008, 0:40 IST Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also under the scanner of the US drug regulator, for more …
HIT hard by mounting scrutiny and falling stocks, Ranbaxy CEO and MD Malvinder Singh said a big global pharma company was trying to scuttle the deal with Daiichi Sankyo. "This is part of a larger game of a global innovater company to block low-cost generic drugs,'' he said. According to …
Ranbaxy Laboratories, the leading Indian pharmaceutical firm, has been in the eye of a storm over allegations by US federal investigators about the manufacturing practices followed at its Paonta Sahib plant in Himachal Pradesh. The plant has what is considered the most prestigious certificate in the world for such an …
Pb Jayakumar / Mumbai July 18, 2008, 0:41 IST Indoco Remedies, a leading Mumbai-based generic drug maker, is planning to launch about 40 drugs in the domestic market within a year. Also, they are forming a new marketing division targeting gynaecologists and paediatricians. Most drug launches will be in its …
After rising 15 per cent Wednesday, the Ranbaxy stock resumed its downward journey on reports in the US media that a US Congressional Committee will examine Ranbaxy's drug approvals in the US and potential violations of manufacturing regulations. The committee will also scrutinise the US drug regulator Food and Drug …
AUS Congressional Committee is launching an investigation into whether US Food and Drug Administration (FDA) was lenient in allowing Ranbaxy to sell new drugs in the US market when it was still investigating discrepancies at the Indian pharma major's manufacturing facility in India. The committee will also examine whether the …
The Ranbaxy sale to Daiichi Sankyo could herald a new phase in the evolution of the Indain pharmaceutical industry. In order to cope in a world after the agreement on Trade-related Aspects of Intellectual Property Rights came into force, some of the larger Indian firms pursued the two strategies of …
